Chrystal Louis

Chrystal Louis

No open positions remaining

Net worth: - $ as of 30/08/2026

50 year
Health Technology
Consumer Services

Profile

Dr. Chrystal U.
Louis
was previously employed as a Chief Medical Officer by TScan Therapeutics, Inc., a Senior VP-Hematology Clinical Development by Zentalis Pharmaceuticals, Inc., a Vice President & Head-Medical Affairs by CRISPR Therapeutics, Inc., and an Executive Director-Myeloid Diseases by Celgene Corp.
She received her undergraduate degree from Southwestern University, a graduate degree from Tulane University School of Medicine and a doctorate degree from Tulane University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2026 0 ( -.--% ) - $ 30/08/2026

Former positions of Chrystal Louis

CompaniesPositionEnd
TSCAN THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/09/2026
ZENTALIS PHARMACEUTICALS, INC. Corporate Officer/Principal 29/02/2024
Corporate Officer/Principal 31/10/2022
CELGENE Corporate Officer/Principal 31/12/2018
See the detail of Chrystal Louis's experience

Training of Chrystal Louis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Chrystal Louis
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!